Elkins David V
SEC CIK 1451604 · EDGAR
BoughtSold
Most active insiders at BMY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Elkins David V | EVP, CFO | — | $1.85M |
| 2 | Massacesi Cristian | EVP, Chief Med Offr, Head of Dev | — | $403.5K |
| 3 | Holzer Phil M | SVP, Ctrl | — | $33.8K |
| 4 | Short Bartie Wendy | EVP, Corp. Affairs | — | — |
| 5 | Hoch Lynelle | Pres, Cell Therapy Org | — | — |
| 6 | Poole Ahn Amanda | EVP, CHRO | — | — |
| 7 | Gallman Cari | EVP, GC | — | — |
| 8 | Lenkowsky Adam | EVP, Chief Commercial Off | — | — |
| 9 | Shanahan Karin | EVP, Chief Supply Chain, Ops | — | — |
| 10 | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | — | — |
Transactions 36
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-04-02 16:29 | 2026-04-01 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | S - Sale | $61.67 | -30.0K | 159.2K | -16% | -$1.85M |
| DM | 2026-03-12 | 2026-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | J - Other | $0.00 | -25.0K | 178.3K | -12% | $0 |
| DM | 2026-03-12 | 2026-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +63.0K | 175.0K | +56% | $0 |
| DM | 2026-03-12 | 2026-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | F - Tax | $60.13 | -16.1K | 171.3K | -9% | -$968.9K |
| 2025-11-14 | 2025-11-13 | TPR | Tapestry, Inc. | Elkins David V | Dir | A - Grant | $100.76 | +1,985 | 7,347 | +37% | +$200.0K | |
| 2025-09-03 | 2025-09-02 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | S - Sale | $47.33 | -56.0K | 167.4K | -25% | -$2.65M | |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | J - Other | $0.00 | -20.2K | 202.5K | -9% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +69.5K | 206.9K | +51% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | F - Tax | $63.11 | -20.9K | 199.3K | -10% | -$1.32M |
| 2024-11-15 | 2024-11-14 | TPR | Tapestry, Inc. | Elkins David V | Dir | A - Grant | $57.82 | +3,459 | 5,290 | +189% | +$200.0K | |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | F - Tax | $53.79 | -18.5K | 176.9K | -9% | -$996.3K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | J - Other | $0.00 | -19.4K | 175.4K | -10% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +64.3K | 181.1K | +55% | $0 |
| D | 2024-03-01 | 2024-02-29 | TPR | Tapestry, Inc. | Elkins David V | Dir | A - Grant | $47.53 | +1,788 | 1,788 | New | +$85.0K |
| D | 2023-12-05 | 2023-12-02 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +8,792 | 172.3K | +5% | $0 |
| D | 2023-12-05 | 2023-12-02 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | F - Tax | $50.10 | -3,730 | 168.6K | -2% | -$186.9K |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | J - Other | $0.00 | +8,930 | 141.2K | +7% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | F - Tax | $65.71 | -41.3K | 137.2K | -23% | -$2.72M |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +71.9K | 140.9K | +104% | $0 |
| D | 2022-12-06 | 2022-12-02 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +8,792 | 128.6K | +7% | $0 |
| D | 2022-12-06 | 2022-12-02 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | F - Tax | $81.13 | -4,498 | 124.1K | -3% | -$364.9K |
| DM | 2022-09-15 | 2022-09-13 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $48.49 | +123.3K | 102.5K | New | +$5.98M |
| DM | 2022-09-15 | 2022-09-13 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | S - Sale+OE | $71.30 | -134.0K | 100.5K | -57% | -$9.55M |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +16.1K | 134.1K | +14% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | J - Other | $0.00 | +1,962 | 135.0K | +1% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | F - Tax | $68.42 | -9,222 | 126.1K | -7% | -$631.0K |
| D | 2022-03-03 | 2022-03-01 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | F - Tax | $68.63 | -10.4K | 121.7K | -8% | -$712.4K |
| D | 2022-03-03 | 2022-03-01 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +24.6K | 132.0K | +23% | $0 |
| D | 2022-01-04 | 2021-12-31 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +47.4K | 131.7K | +56% | $0 |
| D | 2022-01-04 | 2021-12-31 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | F - Tax | $62.35 | -24.2K | 107.5K | -18% | -$1.51M |
| D | 2021-12-06 | 2021-12-02 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | F - Tax | $55.41 | -4,498 | 84.3K | -5% | -$249.2K |
| D | 2021-12-06 | 2021-12-02 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +8,792 | 88.8K | +11% | $0 |
| DM | 2021-08-16 | 2021-08-12 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | S - Sale+OE | $66.95 | -99.7K | 80.0K | -55% | -$6.67M |
| DM | 2021-08-16 | 2021-08-12 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $48.49 | +70.0K | 80.0K | +699% | +$3.39M |
| D | 2021-08-03 | 2021-08-01 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +46.4K | 133.4K | +53% | $0 |
| D | 2021-08-03 | 2021-08-01 | BMY | Bristol Myers Squibb | Elkins David V | EVP, CFO | F - Tax | $67.87 | -23.7K | 109.7K | -18% | -$1.61M |
Purchase Sale Sale after option exercise All abbreviations